Baxter Recalls Cefazolin Injection Bags Due to Particulate Matter
Baxter Healthcare is recalling 19,032 bags of Cefazolin Injection due to the presence of particulate matter. The affected product is distributed nationwide in the US.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 per the rubric. The presence of particulate matter in an intravenous injection poses a significant risk of harm.
Plain-English summary
Baxter Healthcare Corporation is recalling 19,032 bags of Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag. The recall is being conducted because of the presence of particulate matter in the product. The affected product is identified by Lot # LD175708 with an expiration date of 14-Feb-2027.
The recalled product is a sterile, frozen premix infusion bag manufactured by Baxter Healthcare Corporation in Deerfield, IL. It is distributed nationwide in the United States. The product is a prescription-only medication intended for intravenous use.
Healthcare providers and patients should stop using the affected product immediately. Consumers should check their inventory for the specific lot number and expiration date listed above. If the product is found, it should be returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- CEFAZOLIN (CEFAZOLIN SODIUM)
- Brand
- CEFAZOLIN
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — Antibiotic Injection
- Affected units
- 19,032
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # LD175708
- Exp Date: 14-Feb-2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEFAZOLIN
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- ModerateCardinal Health Recalls Cefazolin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Baxter Healthcare Corporation
See all →- ModerateBaxter PRO+ Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter Recalls Two VOLARA Systems Due to Potential Flow Rate Inaccuracy
FDA (Devices) · 2026-09-30
- ModerateBaxter Recalls PRO+ MRS Mattress Due to UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter PRO+ 36-inch Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- SevereB. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter
FDA (Drugs) · 2014-05-07
- CriticalBaxter Recalls 5% Dextrose Injection Bags Due to Metal Particulate Matter
FDA (Drugs) · 2015-07-15
- SevereB. Braun Recalls Cefoxitin and Dextrose Injectable Due to Particulate Matter
FDA (Drugs) · 2014-05-07
- HighBaxter Recalls Famotidine Injection Due to Plastic and Rubber Particulate Matter
FDA (Drugs) · 2014-12-17
- SevereBaxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter
FDA (Drugs) · 2026-09-16
- CriticalBaxter Recalls 10% Dextrose Injection Bags Due to Metal Particulate Matter
FDA (Drugs) · 2015-07-15